CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
Authors:
- N MasudaNMN Masuda
- S NegoroSNS Negoro
- K MatsuiKMK Matsui
- T YanaTYT Yana
- S KudohSKS Kudoh
- Y KusunokiYKY Kusunoki
- M TakadaMTM Takada
- M KawaharaMKM Kawahara
- M OgawaraMOM Ogawara
- N KodamaNKN Kodama
- K KubotaKKK Kubota
Open Access
- 1 January 1997
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (2) , 306-309
Abstract
Sixty-three patients with extensive-stage small-cell lung cancer were randomized to receive either cyclophosphamide, vincristine, doxorubicin and etoposide (CODE) alone or CODE plus recombinant human granulocyte colony-stimulating factor (rhG-CSF). rhG-CSF administration in support of CODE chemotherapy resulted in increased mean total received dose intensity for all drugs (P = 0.03) with a significant improvement in survival (P = 0.004).Keywords
This publication has 17 references indexed in Scilit:
- Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.Journal of Clinical Oncology, 1995
- A Pilot Study of Intensive Weekly Chemotherapy for Extensive Disease Small-Cell Lung CarcinomaCancer Investigation, 1992
- Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer.Journal of Clinical Oncology, 1991
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Brief Intensive Chemotherapy for Metastatic Non-Small-Cell Lung Cancer: A Phase II Study of the Weekly CODE RegimenJNCI: Journal of the National Cancer Institute, 1991
- Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.Journal of Clinical Oncology, 1991
- Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot study.Journal of Clinical Oncology, 1990
- Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerBritish Journal of Cancer, 1987
- Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop.1983
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977